Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib

Patients with non‐small cell lung cancer (NSCLC) and uncommon epidermal growth factor receptor (EGFR) mutation are characterized by high heterogeneity, and globally considered to have a worse prognosis than patients with the two common mutations; exon 19 deletion, and exon 21 L858R. Nevertheless, so...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Vito, Catino, Annamaria, Montrone, Michele, Pizzutilo, Pamela, Pesola, Francesco, Marech, Ilaria, Capone, Iolanda, Prelaj, Arsela, Galetta, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258364/
https://www.ncbi.nlm.nih.gov/pubmed/34008923
http://dx.doi.org/10.1111/1759-7714.13953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258364/
https://www.ncbi.nlm.nih.gov/pubmed/34008923
http://dx.doi.org/10.1111/1759-7714.13953

Ejemplares similares